Gastrointestinal symptoms that some patients experience while on GLP-1 therapysuch as nausea, reduced appetite, or altered bowel habitsgenerally resolve as the medication clears from the system, typically within 1-2 weeks for short-acting formulations and within 4-8 weeks for long-acting preparations, corresponding to their elimination timelines
At SpadeRx, we believe better health starts with accessibility, clarity, and science-backed treatment
Healthcare providers should evaluate micronutrient intake, including B-vitamins, as clinically indicated during weight-loss interventions , rather than relying on fixed-dose supplementation for specific clinical effects
signs of bowel obstruction (severe abdominal distension, absence of stool/gas, vomiting)